Brendan Teehan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brendan Teehan
Pacira BioSciences, Inc. reported in an 8-K filed January 21, 2025 that Brendan Teehan was appointed Chief Commercial Officer. Pacira BioSciences, Inc. reported in an 8-K filed January 21, 2025 that Brendan Teehan was appointed Chief Commercial Officer, effective January 21, 2025. Brendan Teehan has spoken on 1 earnings call across 1 company, most recently for Pacira BioSciences, Inc. on February 26, 2026.
“Brendan Teehan has been named Chief Commercial Officer and Krys Corbett, Esq. has been named Chief Business Officer.”
“On January 16, 2025, Brendan Teehan was appointed Chief Commercial Officer of Pacira BioSciences, Inc. (the "Company"), effective January 21, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Pacira BioSciences, Inc. (PCRX)
Proxy statement
Current2025-01-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Pacira BioSciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Frank D. Lee CEO, Board Member
- Laura Brege Chairman, Board Member
- Paul Hastings Chairman, Board Member
- Lauren Riker CFO
- Shawn M. Cross CFO
- Daryl Gaugler COO
- Abraham Ceesay Board Member
- Alethia Young Board Member
- Christopher Christie Board Member
- Christopher J. Christie Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.